Sphere Entertainment stock soars over 10% after Las Vegas venue opening

Sphere Entertainment stock soars over 10% after Las Vegas venue opening


The Sphere is seen during the opening night with U2:UV Achtung Baby Live concert at the Venetian Resort in Las Vegas, Nevada, United States on September 29, 2023. 

Tayfun Coskun | Anadolu Agency | Getty Images

Sphere Entertainment shares soared more than 10% Monday morning following the successful opening weekend of the company’s new Las Vegas venue.

The entertainment and media company, a pet project of New York Knicks owner James Dolan, paired its venue opening with a performance from rock band U2 on both Saturday and Sunday night. The Sphere plans to host live concerts and sporting events.

Fans took to social media to share their excitement at the performances, which appeared to have a big turnout.

Sphere calls itself a “next-generation entertainment medium” that aims to bring a fresh take to live entertainment, fit with a futuristic dome-shaped arena and wall-to-wall video screens. The Las Vegas venue is the company’s first opening.

The company has also announced plans to build another Sphere in London, pending approvals.

The company’s market cap sits at around $1.4 billion.





Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More